Phase 1CompletedAge-related condition
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics of DKF-310 Intramuscular Injection in Healthy Male Volunteers
- Sponsor
- Dongkook Pharmaceutical Co., Ltd. (Industry)
- Enrolment
- 44 enrolled
- Conditions
- Alzheimer's Disease
- Interventions
- DKF-310; Placebo
- Ages
- adults
- Registry
- NCT02695004
Full record on ClinicalTrials.gov
From the registry
This is a study to evaluate safety, tolerability and PK of DKF-310 IM injection in healthy male volunteers.
Primary outcomes
- AUC
- Cmax
History
Last registry update
Primary completion
Registered
Started